Korsana Biosciences, Inc. (KRSA) Net Income by Year
Korsana Biosciences, Inc. reported a net loss of $3.5M in fiscal year 2025. This represents a decrease of 15.4% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $6.7M net loss. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Korsana Biosciences, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
KRSA Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
KRSA Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Korsana Biosciences, Inc. financials
Frequently Asked Questions
What was Korsana Biosciences, Inc.'s net income in fiscal year 2025?
Korsana Biosciences, Inc. reported a net loss of $3.5M in fiscal year 2025.
How fast is Korsana Biosciences, Inc.'s net income growing?
Korsana Biosciences, Inc. (KRSA) net income fell by 15.4% year over year, from -$3.1M to -$3.5M in fiscal year 2025.
What is Korsana Biosciences, Inc.'s net income over the last twelve months?
Korsana Biosciences, Inc. (KRSA) reported a $6.7M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
What was Korsana Biosciences, Inc.'s net income in the most recent quarter?
Korsana Biosciences, Inc. (KRSA) reported -$1.8M in net income in Q2 2026. This represents a decrease of 441.7% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Korsana Biosciences, Inc. (KRSA) reported on that line in every period on record.